100 related articles for article (PubMed ID: 28939555)
1. A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate (LDC).
Shimomura O; Oda T; Tateno H; Ozawa Y; Kimura S; Sakashita S; Noguchi M; Hirabayashi J; Asashima M; Ohkohchi N
Mol Cancer Ther; 2018 Jan; 17(1):183-195. PubMed ID: 28939555
[TBL] [Abstract][Full Text] [Related]
2. Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.
Yang Y; Akashi Y; Shimomura O; Tateno H; Saito S; Hiemori K; Miyazaki Y; Furuta T; Kitaguchi D; Kuroda Y; Pakavarin L; Oda T
Gastric Cancer; 2022 Sep; 25(5):896-905. PubMed ID: 35715659
[TBL] [Abstract][Full Text] [Related]
3. Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.
Kimura S; Oda T; Shimomura O; Enomoto T; Hashimoto S; Kuroda Y; Yu Y; Kurimori K; Furuta T; Miyazaki Y; Tateno H
Eur Surg Res; 2020; 61(4-5):113-122. PubMed ID: 33503609
[TBL] [Abstract][Full Text] [Related]
4. Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer.
Kuroda Y; Oda T; Shimomura O; Hashimoto S; Akashi Y; Miyazaki Y; Furuya K; Furuta T; Nakahashi H; Louphrasitthiphol P; Mathis BJ; Nakajima T; Tateno H
Int J Cancer; 2023 Apr; 152(7):1425-1437. PubMed ID: 36412556
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
[TBL] [Abstract][Full Text] [Related]
6. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma.
Tada K; Ohta M; Hidano S; Watanabe K; Hirashita T; Oshima Y; Fujnaga A; Nakanuma H; Masuda T; Endo Y; Takeuchi Y; Iwashita Y; Kobayashi T; Inomata M
Surg Today; 2020 Jul; 50(7):767-777. PubMed ID: 31950256
[TBL] [Abstract][Full Text] [Related]
7. Lectin drug conjugate therapy for colorectal cancer.
Kitaguchi D; Oda T; Enomoto T; Ohara Y; Owada Y; Akashi Y; Furuta T; Yu Y; Kimura S; Kuroda Y; Kurimori K; Miyazaki Y; Furuya K; Shimomura O; Tateno H
Cancer Sci; 2020 Dec; 111(12):4548-4557. PubMed ID: 33058342
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
9. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
10. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
[TBL] [Abstract][Full Text] [Related]
11. Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study.
Watanabe K; Ohta M; Yada K; Komori Y; Iwashita Y; Kashima K; Inomata M
Surg Today; 2016 Oct; 46(10):1217-23. PubMed ID: 26754572
[TBL] [Abstract][Full Text] [Related]
12. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
13. Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells.
McCarter C; Kletter D; Tang H; Partyka K; Ma Y; Singh S; Yadav J; Bern M; Haab BB
Proteomics Clin Appl; 2013 Oct; 7(9-10):632-41. PubMed ID: 23956151
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
[TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated diagnosis of pancreatic cancer using lectin-conjugated nanoparticles bound to selective glycans.
Choi Y; Park U; Koo HJ; Park JS; Lee DH; Kim K; Choi J
Biosens Bioelectron; 2021 Apr; 177():112980. PubMed ID: 33450614
[TBL] [Abstract][Full Text] [Related]
16. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
17. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
18. Two Chitotriose-Specific Lectins Show Anti-Angiogenesis, Induces Caspase-9-Mediated Apoptosis and Early Arrest of Pancreatic Tumor Cell Cycle.
Singh R; Nawale L; Sarkar D; Suresh CG
PLoS One; 2016; 11(1):e0146110. PubMed ID: 26795117
[TBL] [Abstract][Full Text] [Related]
19. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
20. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]